JPRN-UMIN000008551已完成未知
A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnaires - GERD treatment period study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patiets with the history of gastric surgeries Patients with alarm symptoms such as vomiting, GI bleeding, rapid body weight loss Patients of alcohol or drug dependence Patients with severe endocrine problems Patients with severe injuries of heart, liver, kidney or bone marrow functions Patients with allergy against the test drugs Patients with pregnancy, possible pregnancy or breast feeding, or hope of pregnancy during the test period Patients whom the doctor decide as not proper for the study
研究者
相似试验
已完成
不适用
Prospective observational study of relapsed and refractory pediatric acute lymphoblastic leukemiaacute lymphoblastic leukemiaJPRN-UMIN000019878Japanese Pediatric Leukemia/Lymphoma Study Group76
已完成
不适用
Comparison of Cure and Relapse Rate of the Symptoms in Umbilical Pilonidal Sinus in two surgical way complete sinus excision with reconstruction of umbilicus and sinus excision with umbilical preservatioPilonidal cyst.Pilonidal cyst without abscessIRCT2013011912172N1Vice chancellor for research, Kashan University of Medical Sciences and Health Services60
已完成
2 期
Velcade™ (bortezomib) combination chemotherapy in AL amyloidosisCancerISRCTN33283585niversity College London (UCL) (UK)52
已完成
不适用
A descriptive study of Relapsing-Remitting Multiple Sclerosis (RRMS) treated with first disease modifying therapies (DMTs) in current UK clinical practice: patterns of clinical decision making and the patient experience of relapseNervous System DiseasesMultiple SclerosisMultiple sclerosisISRCTN66678006ovartis Pharmaceuticals Ltd (UK)150
进行中（未招募）
1 期
A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 and Dimethyl FumarateRelapsing-Remitting Multiple SclerosisMedDRA version: 20.0 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disordersEUCTR2017-001294-16-DEAlkermes, Inc.500